Home » Market News » DirectorsTalk Highlights » 32 Million Americans Suffer From This Skin Condition—Is Your Baby One of Them?
SkinBiotherapeutics Plc

32 Million Americans Suffer From This Skin Condition—Is Your Baby One of Them?

Before this spring, I’d only heard about eczema (the most common type of which is known as atopic dermatitis) in lotion commercials I’d seen on the TV, and to be completely honest, I didn’t really know what it was.

SkinBioTherapeutics (LON:SBTX) is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.